Acadia Healthcare’s (ACHC) “Neutral” Rating Reaffirmed at Cantor Fitzgerald

Cantor Fitzgerald reiterated their neutral rating on shares of Acadia Healthcare (NASDAQ:ACHCFree Report) in a research report released on Tuesday morning,Benzinga reports. They currently have a $25.00 price objective on the stock.

Other research analysts also recently issued reports about the stock. Cowen reiterated a “buy” rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Guggenheim lowered their price target on shares of Acadia Healthcare from $36.00 to $29.00 and set a “buy” rating for the company in a report on Thursday, August 7th. Raymond James Financial boosted their price objective on shares of Acadia Healthcare from $26.00 to $30.00 and gave the stock an “outperform” rating in a research note on Friday. Bank of America lowered Acadia Healthcare from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $27.00 to $25.00 in a research report on Wednesday, September 10th. Finally, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a report on Saturday, September 27th. Eight equities research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $36.91.

Read Our Latest Stock Report on Acadia Healthcare

Acadia Healthcare Stock Up 2.9%

Shares of NASDAQ:ACHC opened at $27.23 on Tuesday. The company has a fifty day moving average of $22.43 and a 200-day moving average of $23.46. The company has a market capitalization of $2.51 billion, a PE ratio of 18.03, a price-to-earnings-growth ratio of 5.24 and a beta of 0.90. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.32 and a current ratio of 1.32. Acadia Healthcare has a 52-week low of $17.13 and a 52-week high of $60.52.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.12. The company had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The company’s revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the prior year, the business earned $0.91 earnings per share. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. On average, equities analysts predict that Acadia Healthcare will post 3.38 EPS for the current fiscal year.

Institutional Trading of Acadia Healthcare

A number of institutional investors have recently bought and sold shares of ACHC. GAMMA Investing LLC boosted its position in Acadia Healthcare by 7,291.8% during the first quarter. GAMMA Investing LLC now owns 176,220 shares of the company’s stock valued at $5,812,000 after acquiring an additional 173,836 shares during the last quarter. UMB Bank n.a. boosted its position in shares of Acadia Healthcare by 149.5% during the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company’s stock worth $38,000 after purchasing an additional 755 shares in the last quarter. Envestnet Portfolio Solutions Inc. bought a new position in shares of Acadia Healthcare during the 1st quarter worth about $222,000. Teacher Retirement System of Texas bought a new position in shares of Acadia Healthcare during the 1st quarter worth about $412,000. Finally, Palisade Capital Management LP boosted its position in shares of Acadia Healthcare by 2.1% during the 1st quarter. Palisade Capital Management LP now owns 613,332 shares of the company’s stock worth $18,596,000 after purchasing an additional 12,807 shares in the last quarter.

Acadia Healthcare Company Profile

(Get Free Report)

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.

Further Reading

Analyst Recommendations for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.